An experiment has prepared CMD‐CS nanostructures for colorectal tumor suppression via siRNA and DOX co‐delivery and the nanosystem exhibited high encapsulation efficiency for both high mobility group A2 (HMGA2)‐siRNA (78%) and DOX (75%) and can induce cell death. The gene discussed is HMGA2; the disease is colorectal neoplasm.